Fulgent Genetics Investor Presentation 2024

Fulgent Genetics, Inc. (NASDAQ: FLGT) presented its 2024 investor update covering its molecular diagnostics and genetic testing services, plus its Fulgent Pharma subsidiary focused on cancer care solutions. The presentation outlines the company's business model, leadership team, and strategic initiatives in genomic diagnostics and pharmaceutical development.